China SXT Pharmaceuticals, Inc.

SXTC · NASDAQ
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Operating Activities
Net Income-$3-$3-$6-$6
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$3$0
Stock-Based Comp.$0$0$1$2
Change in WC-$1-$0$1$2
Other Non-Cash$2$1$0$1
Operating Cash Flow-$2-$2-$0$0
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$0-$0
Financing Activities
Debt Repay.-$0$1$4$3
Stock Issued$3$0$2$3
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$6-$4-$3-$4
Financing Cash Flow$8-$3$3$2
Forex Effect-$0-$1-$1$0
Net Chg. in Cash$6-$5$2$2
Supplemental Information
Beg. Cash$12$17$16$13
End Cash$18$12$17$16
Free Cash Flow-$2-$2-$0$0